STOCK TITAN

Colgate-Palmolive grants options to growth chief

Colgate-Palmolive’s Chief Growth Officer received new stock option and RSU grants that increase his direct and 401(k) plan-related shareholdings.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) reported that Chief Growth Officer John Hazlin received equity awards on September 16, 2026. He was granted stock options for 27,042 shares of common stock at an exercise price of $87.02 per share, expiring September 16, 2036, which become exercisable in one-third increments beginning on the first anniversary of the grant date. He also received a restricted stock unit award of 3,908 shares that vests in equal one-third installments on each of the first, second and third anniversaries of the grant date. After these awards, he holds 27,021 common shares directly and 5,513 shares indirectly through the issuer’s 401(k) plan, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Hazlin John
Role Chief Growth Officer
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2, F3 27,042 $0.00 $0.00
Grant/Award Common Stock F1 3,908 $0.00 $0.00
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 27,042 contracts (Direct); Common Stock — 27,021 shares (Direct); Common Stock — 5,513 shares (Indirect, By Issuer's 401(k) Plan Trustee)
Footnotes (3)
  1. F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
  2. F2. Stock option award granted under the issuer's incentive compensation plan.
  3. F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.
Stock options granted 27,042 shares Options on common stock granted to John Hazlin on September 16, 2026
Stock option exercise price $87.02 per share Exercise price for options granted September 16, 2026, expiring September 16, 2036
Restricted stock units granted 3,908 shares RSU award to John Hazlin on September 16, 2026, vesting over three years
Direct common shares after awards 27,021 shares Direct ownership of Colgate-Palmolive common stock following the reported transactions
Indirect 401(k) plan shares 5,513 shares Common stock held indirectly by issuer’s 401(k) plan trustee for John Hazlin
Option expiration date September 16, 2036 Expiration date of the 27,042 stock options granted to John Hazlin
RSU vesting installments 1/3 each year for 3 years RSUs vest in equal one-third installments on first, second, and third anniversaries
restricted stock unit financial
"Restricted stock unit award granted under the issuer's incentive compensation plan."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"Stock option award granted under the issuer's incentive compensation plan."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
incentive compensation plan financial
"award granted under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
401(k) Plan financial
"By Issuer's 401(k) Plan Trustee"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did CL grant to Chief Growth Officer John Hazlin on September 16, 2026?

On September 16, 2026, John Hazlin received 27,042 stock options with an exercise price of $87.02 per share and a 3,908-share restricted stock unit award under Colgate-Palmolive’s incentive compensation plan.

How do John Hazlin’s new stock options in CL vest and when do they expire?

The 27,042 stock options become exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date and expire on September 16, 2036, according to the filing.

What is the vesting schedule for John Hazlin’s new restricted stock units in CL?

The 3,908 restricted stock units vest in equal one-third installments on each of the first, second and third anniversaries of the September 16, 2026 grant date, under Colgate-Palmolive’s incentive compensation plan.

How many CL common shares does John Hazlin hold directly after these transactions?

After the reported awards, John Hazlin directly holds 27,021 shares of Colgate-Palmolive common stock, in addition to his new option and restricted stock unit grants.

What indirect CL holdings does John Hazlin have through the company’s 401(k) plan?

The filing reports that John Hazlin has 5,513 shares of Colgate-Palmolive common stock held indirectly by the issuer’s 401(k) plan trustee, in addition to his direct holdings.

Were John Hazlin’s CL transactions made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, so no Rule 10b5-1 trading plan is reported in connection with these equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hazlin John

(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NEW YORK 10022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Growth Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/16/2026A(1)3,908A$0.000027,021D
Common Stock5,513IBy Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$87.0209/16/2026A(2)27,042 (3)09/16/2036Common Stock27,042$0.000027,042D
Explanation of Responses:
1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
2. Stock option award granted under the issuer's incentive compensation plan.
3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact09/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading